Project description
Safeguarding cells in cell-based therapies
Over the years, various cell-based therapies have been developed against a wide range of diseases, including genetic disorders and cancer. Despite their preclinical promise, cell-based therapies suffer from low engraftment and retention of injected cells. To address this shortcoming, scientists of the EU-funded NOAHs-ARK project propose an encapsulation technology that safeguards cells against immune attack and supports their function. The technology consists of a chemically defined template enriched with various novel molecules suitable for specific therapeutic applications. Following in vitro validation, the technology will obtain regulatory approval before being commercialised for clinical application.
Fields of science
Programme(s)
Funding Scheme
CSA-LSP - Coordination and support action Lump sum
Coordinator
4805-017 Barco Gmr
Portugal
See on map